BluGlass Secures A$8 Million to Accelerate GaN Laser Growth with Board Support

Upsized Placement Boosts BluGlass Capital

BluGlass Limited (ASX:BLG) has successfully raised A$8 million through a two-tranche placement priced at A$0.24 per share, marking a strategic capital injection to accelerate its gallium nitride (GaN) laser production. Notably, board and management are anchoring the raise with a combined A$2.3 million commitment, including a substantial A$2 million from Executive Chair Omer Granit. This internal backing underscores confidence in BluGlass’ growth trajectory and technology.

The placement includes one free attaching option per share exercisable at A$0.38, expiring in May 2028, pending shareholder approval. The shares are being issued at a discount ranging from 3.7% to 17.2% against recent volume weighted and last traded prices, reflecting a pricing strategy to secure strong institutional support.

Scaling GaN Laser Operations Amid Robust Demand

Proceeds from the placement will fund the scaling of BluGlass’ GaN laser operations, acquisition of additional fabrication equipment, and support for both new and existing contracts. Executive Chair Granit highlighted the company’s momentum, with nearly US$3 million in recent development contracts and a project pipeline exceeding US$100 million. He emphasised the strategic importance of GaN lasers across emerging technologies and the company’s positioning to capture market share as adoption grows exponentially.

CEO Jim Haden pointed to BluGlass’ expanding customer roster, which includes the U.S. Department of War, the Indian Ministry of Defence, Tier 1 defence primes, and Fortune 500 technology companies. This diverse base reflects BluGlass’ unique status as one of only two GaN laser suppliers with U.S. manufacturing facilities, a critical advantage amid increasing government onshoring of strategic manufacturing capabilities.

Institutional Confidence and Strategic Partnerships

The placement follows a series of contract wins and collaborations, including a recent A$1.3 million photonics R&D deal with a Fortune 500 data storage leader, which underscores BluGlass’ expanding footprint in high-value photonics markets. This deal, among others, illustrates the company’s ability to leverage its proprietary RPCVD technology and novel device architectures to meet sophisticated customer demands across defence, aerospace, quantum, and biotech sectors.

Bell Potter Securities acted as lead manager and bookrunner, securing a 6% fee on funds raised and 2 million options, aligning incentives with BluGlass’ capital raising success. The company has scheduled an Extraordinary General Meeting for late May to seek shareholder approval for director participation and the issue of attaching options, which will finalise the placement’s capital structure.

Meanwhile, the interim executive services agreement for Mr Granit, effective until end-April 2026, signals ongoing executive leadership stability as the board finalises his remuneration package. This leadership continuity is critical as BluGlass navigates its next growth phase.